Alliancebernstein L.P. Passage Bio, Inc. Transaction History

Alliancebernstein L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.63 - $3.46 $25,591 - $54,322	-15,700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.24 - $10.2 $1,248 - $2,039	200 Added 1.29%	15,700 $100,000
Q3 2021 Nov 10, 2021	SELL	$9.73 - $15.52 $25,298 - $40,352	-2,600 Reduced 14.36%	15,500 $154,000
Q2 2021 Jul 30, 2021	BUY	$12.44 - $19.45 $79,616 - $124,480	6,400 Added 54.7%	18,100 $240,000
Q1 2021 May 06, 2021	SELL	$16.24 - $29.83 $123,423 - $226,708	-7,600 Reduced 39.38%	11,700 $205,000
Q4 2020 Feb 08, 2021	SELL	$14.28 - $29.73 $2,856 - $5,946	-200 Reduced 1.03%	19,300 $494,000
Q3 2020 Nov 12, 2020	BUY	$12.39 - $26.15 $66,906 - $141,210	5,400 Added 38.3%	19,500 $256,000
Q2 2020 Aug 13, 2020	BUY	$14.59 - $36.07 $205,719 - $508,587	14,100 New	14,100 $385,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $31.6M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.